1. Home
  2. Documents

Antiretroviral Therapy and HIV Drug Resistance Documents

Date Range
cover
HIV drug resistance report 2019
Technical and scientific products
cover
Guidelines on the public health response to pretreatment HIV drug resistance: July 2017
Technical and scientific products
cover
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV. Interim guidance; 2018 (Sólo en inglés)
Technical and scientific products
cover
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Policy brief
Technical and scientific products
Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations
Transition to new antiretroviral drugs in HIV programmes: clinical and programmatic considerations
Technical and scientific products
Appropriate medicines: options for pre-exposure prophylaxis
Appropriate medicines: options for pre-exposure prophylaxis
Guidelines
cover
Global Action Plan on HIV Drug Resistance 2017–2021. Progress report
Mandates and Strategies
cover
WHO implementation tool for monitoring the toxicity of new antiretroviral and antiviral medicines in HIV and viral hepatitis programmes
Technical and scientific products
cover
Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children; 2018
Technical and scientific products
cover
Tackling HIV drug resistance: trends, guidelines and global action; 2017
Mandates and Strategies
cover
TB/HIV Coinfection Regional Clinical Manual. (2017 Update); 2018
Technical and scientific products
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance - Policy brief; 2018
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance - Policy brief; 2018 (Sólo en inglés)
Technical and scientific products
Technical consultation on antiretroviral treatment optimization and strategies for access to dolutegravir in Latin America and the Caribbean from a public health perspective
Technical and scientific products
cover
Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis. Concept note; 2017
Technical and scientific products
cover
HIV Treatment. Transition to new antiretrovirals in HIV programmes
Technical and scientific products
Global action plan on HIV drug resistance 2017–2021
Global action plan on HIV drug resistance 2017–2021
Mandates and Strategies
cover
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy
Technical and scientific products
Frequently asked questions: testing for HIV, including HIV self-testing, in the context of pre-exposure prophylaxis (‎PrEP)
Frequently asked questions: testing for HIV, including HIV self-testing, in the context of pre-exposure prophylaxis (‎PrEP)
Guidelines
cover
Consolidated guidelines on person centred hiv patient monitoring and case surveillance. Annex 2.4.6 HIVDR EWI sampling, abstraction and reporting guidance; 2017
Technical and scientific products
cover
WHO/HIVResNet HIV drug resistance laboratory operational framework
Mandates and Strategies
cover
HIV drug resistance report 2017
Technical and scientific products